Both the US and China are putting forward national biotech strategies. Here is an idea of the disruptions to expect.
Tag: China
Chinese venture capital deals fall — but not in energy
The value of VC deals in China tumbled 44% to $62.1bn by the end of October, but energy-related startups are still raising big rounds.
What the world could learn from China’s supercluster strategy
China has a policy of superclusters to drive growth and is increasingly incorporating corporate venture capital initiatives into these clusters.
Bytedance posts $75.6bn in mark-to-market losses
Such enormous losses help explain why Bytedance in January said it was dissolving its corporate venturing unit.
Corporate venturing deal value down 42% in Q2
Corporates are still investing in startups but valuations have fallen dramatically. Some areas such as China and healthcare have been hit hard.
Didi is a symbol of fragmenting capital markets
The Chinese ride-hailing company’s pullback from US markets emblematic of a shift to more geopolitically divided capital.
This is how Chinese VC differs from US and European VC
Financial performance of a sample of Chinese VCs ranged from 14% to 30% per annum, more stable than the range of returns of European and US VC.